SEARCH RESULT

Total Matching Records found : 1343

Cancer survival rate in India among the lowest in the world -Subodh Verma

-The Times of India NEW DELHI: Cancer is thought to be the great leveler. Whether you are an Indian or a Korean or Icelander, cancer will bring death. But a massive study of 26 million cancer Patients over 15 years has shown that survival rates in the 10 most prevalent types of cancer vary hugely across countries. Survival rates in India are quite low for most types of cancer, less than...

More »

Drugs on hold over doubts about Indian trials

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...

More »

‘Chemical farming destroyed Punjab, now MP should be cautious’ -Vivek Trivedi

-ETV/ News 18 Claiming that the excessive use of chemical fertilizers and pesticides destroyed Punjab in the two decades, volunteers from Punjab - once an agri-role model-have cautioned Madhya Pradesh against the same. These volunteers from Kheti Virasat Mission - a group of volunteer activists from different fields working in Punjab for promoting organic farming, said this while participating in Vikalp Mela as part of Bhopal gas tragedy's 30th anniversary events in...

More »

MNCs deprive India of vital drugs -Rupali Mukherjee

-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...

More »

Campaign against Govt's move to cut social sector spending from Nov 30 -Aditi Nigam

-The Hindu Business Line Questioning the kind of growth model pursued by the Government, civil society activists on Saturday called for a wider public debate on the reported move to curtail social sector spending on schemes such as the rural job guarantee scheme, MGNREGA, and for the HIV affected. "Considering the fact that the Government is forecasting a 5.3 per cent growth rate for this year, the social sector cuts in Budget...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close